2-Amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitriles with Microtubule-Disruptive, Centrosome-Declustering, and Antiangiogenic Effects in vitro and in vivo

ChemMedChem. 2022 May 18;17(10):e202200064. doi: 10.1002/cmdc.202200064. Epub 2022 Mar 16.

Abstract

A series of fifteen 2-amino-4-aryl-5-oxo-4,5-dihydropyrano[3,2-c]chromene-3-carbonitriles (1 a-o) were synthesized via a three-component reaction of 4-hydroxycoumarin, malononitrile, and diversely substituted benzaldehydes or pyridine carbaldehydes. The compounds were tested for anticancer activities against a panel of eight human tumor cell lines. A few derivatives with high antiproliferative activities and different cancer cell specificity were identified and investigated for their modes of action. They led to microtubule disruption, centrosome de-clustering and G2/M cell cycle arrest in 518 A2 melanoma cells. They also showed anti-angiogenic effects in vitro and in vivo.

Keywords: Antiangiogenic agents; Anticancer drugs; Centrosome de-clustering; Pyrano[3,2-c]chromene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Benzopyrans* / pharmacology
  • Centrosome
  • Humans
  • Microtubules*
  • Oxotremorine / analogs & derivatives

Substances

  • Angiogenesis Inhibitors
  • Benzopyrans
  • N-methylacetamide-oxotremorine M
  • Oxotremorine